SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer

201628 citationsJournal Articlegold Open Access

Authors

Lauren L. Siewertsz van Reesema · Eastern Virginia Medical School

Vasilena Zheleva · Eastern Virginia Medical School

Janet S. Winston · Sentara Norfolk General Hospital

Rick J. Jansen · North Dakota State University

Carolyn F. O’Connor · Eastern Virginia Medical School

Andrew J. Isbell · Eastern Virginia Medical School

Minglei Bian

Abstract

This work was supported by the Dorothy G. Hoefer Foundation for Breast Cancer Research (A.H. Tang); Center for Innovative Technology (CIT)-Commonwealth Research Commercialization Fund (CRCF) (MF14S-009-LS to A.H. Tang), and National Cancer Institute (CA140550 to A.H. Tang).

Topics & Keywords

Medical Imaging Techniques and Applications HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations

Publication Details

Published in: EBioMedicine

Volume 11, pp. 183-198

DOI: 10.1016/j.ebiom.2016.08.014

Field-Weighted Citation Impact: 1.71

Command Palette

SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer

Authors

Abstract

Topics & Keywords

Publication Details